These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21518950)

  • 21. Federal Medicaid policy. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-36. PubMed ID: 21370530
    [No Abstract]   [Full Text] [Related]  

  • 22. States, safety net providers recover millions from Medicaid fraud schemes.
    Young D
    Am J Health Syst Pharm; 2004 Mar; 61(5):440. PubMed ID: 15018220
    [No Abstract]   [Full Text] [Related]  

  • 23. McKesson settling up. $190 million payment latest in drug-price flap.
    Carlson J
    Mod Healthc; 2012 Apr; 42(18):14. PubMed ID: 22667036
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.
    Greene JA; Padula WV
    N Engl J Med; 2017 Jul; 377(2):101-103. PubMed ID: 28591520
    [No Abstract]   [Full Text] [Related]  

  • 25. Bitter pills for drug companies.
    Newman M
    BMJ; 2010 Sep; 341():c5095. PubMed ID: 20851842
    [No Abstract]   [Full Text] [Related]  

  • 26. The war on drug--prices: states are taking up the fight to reduce prescription drug costs.
    Boulard G
    State Legis; 2002 Mar; 28(3):12-7. PubMed ID: 11873811
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug makers skirting law, Sen. Pryor says.
    Wagner L
    Mod Healthc; 1991 Jan; 21(4):14. PubMed ID: 10108753
    [No Abstract]   [Full Text] [Related]  

  • 28. Private enforcement of state fraud laws: a comparative analysis of state qui tam provisions.
    Boese JT; Haralson SL
    J Health Hosp Law; 1998; 31(1):34-48. PubMed ID: 10179119
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-38. PubMed ID: 30695851
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent case developments in health law. False Claims Act: the right treatment for off-label marketing?
    Wang S
    J Law Med Ethics; 2010; 38(3):708-13. PubMed ID: 20880253
    [No Abstract]   [Full Text] [Related]  

  • 31. Health care fraud: recent developments and timeless advice.
    Bennett RS; Medearis DM
    Tex Med; 2003 Oct; 99(10):50-6. PubMed ID: 14650813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fraud and abuse enforcement revs up.
    Wagner L
    Provider; 1996 Jan; 22(1):71-2. PubMed ID: 10154003
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-38. PubMed ID: 29361660
    [No Abstract]   [Full Text] [Related]  

  • 34. Are Medicaid fraud control units the real fraud? 2.
    Clement NJ; Williams DE; Sanders DP; Apsey D
    J Clin Pediatr Dent; 1991; 15(2):69-80. PubMed ID: 1931749
    [No Abstract]   [Full Text] [Related]  

  • 35. Medicare and state health care programs; fraud and abuse: OIG civil money penalties under the Medicare prescription drug discount card program. Interim final rule with comment period.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2004 May; 69(97):28842-6. PubMed ID: 15151115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent multistate enforcement initiatives: prescription drug promotional practices.
    Woodward D
    Food Drug Law J; 1995; 50(2):295-300. PubMed ID: 10342997
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicare and State Health Care Programs: Fraud and Abuse; Revisions to the Office of Inspector General's Civil Monetary Penalty Rules. Final rule.
    Office of Inspector General (OIG), HHS
    Fed Regist; 2016 Dec; 81(235):88334-65. PubMed ID: 27992157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 39. Why do drug companies fear this man?
    Simons J
    Fortune; 2003 Oct; 148(9):167-8, 170, 172. PubMed ID: 14584310
    [No Abstract]   [Full Text] [Related]  

  • 40. Federal Medicaid policy. Issue brief.
    Miller KG
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-37. PubMed ID: 20217922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.